Wrangling Herd Immunity for a Return to the Office

The arrival of two approved COVID-19 vaccines provides a clear path to the end of the pandemic that held most of 2020 hostage. But a recent resurgence of the virus and skyrocketing rates of infection indicate that a full return to normalcy—including the pre-pandemic work environment— is still months in the future. In this Kenan Insight, we examine the relevant factors that will determine when and how we go back to the office.